Pro-905, a Novel Purine Antimetabolite, Combines with Glutamine Amidotransferase Inhibition to Suppress Growth of Malignant Peripheral Nerve Sheath Tumor

LEMBERG, K. M., ALI, E. S., KREČMEROVÁ, Marcela, AGUILAR, J. M. H., ALT, J., PETERS, D. E., ZHAO, L., WU, Y., NUHA, N., ASARA, J. M., STAEDTKE, V., PRATILAS, C. A., MAJER, Pavel, RAIS, R., BEN-SAHRA, I., SLUSHER, B. S. Pro-905, a Novel Purine Antimetabolite, Combines with Glutamine Amidotransferase Inhibition to Suppress Growth of Malignant Peripheral Nerve Sheath Tumor. Molecular Cancer Therapeutics. 2023, 22(12), 1390-1403. ISSN 1535-7163. E-ISSN 1538-8514. Available: doi: 10.1158/1535-7163.MCT-23-0258.